BMJ 1996;312:509 (24 February)

Letters

Many subjects in trial were not asked for consent

In the UKCCCR multicentre randomised controlled trial of one and two view mammography in breast cancer screening, only one out of the nine breast screening centres that took part sought informed consent before randomisation from the 40 163 women attending their first breast screening examination who participated in this trial.1 The remainder sought consent after randomisation and only from those women who had been allocated to either of the two view arms (ratio 1:1:2)--that is, a quarter of the women in eight out of nine centres did not know they were in a trial.

Might it be assumed that the trial working party decided this because consent is not sought from women "invited" for breast screening? Presumably it was deemed to be unjust to those millions of women who have attended for mammographic screening without benefit of the provision of adequate balanced information that informed consent would confer. Should we not now be asking if it was unjust and unethical for those women in this trial not asked for consent, particularly as the stated conclusion that "two view mammography is medically more effective than one view: it detects more cancers and reduces recall rates; it is also similarly cost effective financially" could hardly be said to be counter intuitive?2 3 4 5

Is it not time that all women who attend for screening are presented with proper, balanced information and asked for consent? It would be particularly interesting to know the opinion of the 9000 or so unsuspecting women who unknowingly participated in this trial. Such better informed women would be better placed to enter into the debate concerning the value (economically and psychologically) of screening in terms of reducing the morbidity and mortality of women with breast cancer.

31 Regent Street, Rowhedge, Colchester CO5 7EA

Hazel Thornton 


  1. Wald NJ, Murphy P, Major P, Parkes Cl, Townsend J, Frost C. UKCCCR multicentre randomised controlled trial of one and two view mammography in breast cancer screening. BMJ 1995;311:1189. (4 November.) [Abstract/Free Full Text]
  2. Anderson I, Hildell J, Muhlow A, Petterson H. Number of projections in mammography: influence on detection of breast disease. AJR 1978;130:349-51. [Abstract]
  3. Anderson I. Radiographic screening for breast carcinoma. III. Appearance of carcinoma and number of projections used at screening. Acta Radiol 1981;22:407.
  4. Sickles EA, Weber WN, Galvin HB, Ominsky SH, Sollitto RA. Baseline screening mammography: one vs two views per breast. AJR 1986;147:1149-53. [Abstract/Free Full Text]
  5. Bassett LW, Bunnell DH, Jahanshahi R, Gold RH, Arndt RD, Linsman J. Breast cancer detection: one versus two views. Radiology 1987;165:95-7. [Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Articles

Not gaining patients' consent in trials is deceitful
Charlotte Williamson
BMJ 1996 312: 1479. [Extract] [Full Text]

UKCCCR multicentre randomised controlled trial of one and two view mammography in breast cancer screening
Nicholas J Wald, Philip Murphy, Philippa Major, Carol Parkes, Joy Townsend, and Chris Frost
BMJ 1995 311: 1189-1193. [Abstract] [Full Text]

This article has been cited by other articles:

  • Williamson, C. (1996). Not gaining patients' consent in trials is deceitful. BMJ 312: 1479a-1479 [Full text]  



Student BMJ

Sepsis

The latest guidlines will affect how we practice medicine

www.student.bmj.com

Listen to the latest BMJ Interview